Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C

Hepatology International

Volumn 3, Issue 4, 2009, Pages 544-550

  Sato, Takahisa ^a   Tateishi, Ryosuke ^a   Yoshida, Haruhiko ^a   Ohki, Takamasa ^a   Masuzaki, Ryota ^a   Imamura, Jun ^a   Goto, Tadashi ^a   Kanai, Fumihiko ^a   Obi, Shuntaro ^a   Kato, Naoya ^a   Shiina, Shuichiro ^a   Kawabe, Takao ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Doubling time; Hepatitis C; Hepatocellular carcinoma; Size of tumor; Surveillance; Surveillance interval; Tumor marker; Ultrasound

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; TUMOR VOLUME;

EID: 73349122295     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-009-9145-y     Document Type: Article

References (31)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents. Lyon (France): IARC Scientific Publications; 2002. (Publication No.: 155)
2. FX Bosch J Ribes M Diaz R Cleries 2004 Primary liver cancer: worldwide incidence and trends Gastroenterology 127 S5 S16 10.1053/j.gastro.2004.09.011 15508102 (Pubitemid 39423365)
3. R Capocaccia M Sant F Berrino A Simonetti V Santi F Trevisani 2007 Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century Am J Gastroenterol 102 1661 1670 10.1111/j.1572-0241.2007.01337.x 17555459 (Quiz 1660, 1671) (Pubitemid 47206702)
4. K Kiyosawa T Umemura T Ichijo A Matsumoto K Yoshizawa A Gad, et al. 2004 Hepatocellular carcinoma: recent trends in Japan Gastroenterology 127 S17 S26 10.1053/j.gastro.2004.09.012 15508082 (Pubitemid 39423366)
5. H Yoshida Y Shiratori M Moriyama Y Arakawa T Ide M Sata IHIT Study Group, et al. 1999 Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan Ann Intern Med 131 174 181 1:CAS:528: DyaK1MXlsVCrtbo%3D 10428733
6. Y Shiratori S Shiina M Imamura N Kato F Kanai T Okudaira, et al. 1995 Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan Hepatology 22 1027 1033 10.1002/hep.1840220403 1:STN:280:DyaK28%2FivFCjtA%3D%3D 7557847
7. CA Sun DM Wu CC Lin SN Lu SL You LY Wang, et al. 2003 Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan Am J Epidemiol 157 674 682 10.1093/aje/kwg041 12697571 (Pubitemid 36423080)
8. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)
9. MF Yuen CC Cheng IJ Lauder SK Lam CG Ooi CL Lai 2000 Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience Hepatology 31 330 335 10.1002/hep.510310211 1:STN:280:DC%2BD3c7it1egsw%3D%3D 10655254
10. L Solmi AM Primerano L Gandolfi 1996 Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases Am J Gastroenterol 91 1189 1194 1:STN:280:DyaK283jslKgtA%3D%3D 8651169
11. BH Zhang BH Yang ZY Tang 2004 Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 417 422 15042359
12. S Shiina T Teratani S Obi S Sato R Tateishi T Fujishima, et al. 2005 A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 122 130 10.1053/j.gastro.2005.04.009 16012942 (Pubitemid 41002049)
13. AC Chan RT Poon KK Ng CM Lo ST Fan J Wong 2008 Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening Ann Surg 247 666 673 10.1097/SLA.0b013e31816a747a 18362630
14. L Bolondi S Sofia S Siringo S Gaiani A Casali G Zironi, et al. 2001 Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Gut 48 251 259 10.1136/gut.48.2.251 1:STN:280:DC%2BD3M7is1WnsQ%3D%3D 11156649 (Pubitemid 32141852)
15. M Makuuchi N Kokudo S Arii S Futagawa S Kaneko S Kawasaki, et al. 2008 Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan Hepatol Res 38 37 51 10.1111/j.1872-034X.2007.00216.x 18039202 (Pubitemid 350182575)
16. T Ohki R Tateishi T Sato R Masuzaki J Imamura T Goto, et al. 2008 Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients Clin Gastroenterol Hepatol 6 459 464 10.1016/j.cgh.2008.02.012 18387499
17. G Torzilli M Minagawa T Takayama K Inoue AM Hui K Kubota, et al. 1999 Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy Hepatology 30 889 893 10.1002/hep.510300411 1:STN:280: DyaK1MvivVCgsQ%3D%3D 10498639 (Pubitemid 29458276)
18. M Nino-Murcia EW Olcott RB Jeffrey Jr RL Lamm CF Beaulieu KA Jain 2000 Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT Radiology 215 746 751 1:STN:280:DC%2BD3c3ptlCnsg%3D%3D 10831693
19. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer 1994 Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1513 1520 10.1002/hep.1840190629 1:STN:280:DyaK2c3ksFWisw%3D%3D 8188183
20. ML Ramirez EC Nelson RW Devere White PN Lara Jr CP Evans 2008 Current applications for prostate-specific antigen doubling time Eur Urol 54 291 300 10.1016/j.eururo.2008.04.003 18439749
21. TM Pawlik KA Delman JN Vauthey DM Nagorney IO Ng I Ikai, et al. 2005 Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma Liver Transpl 11 1086 1092 10.1002/lt.20472 16123959 (Pubitemid 41341758)
22. YS Kim HK Lim H Rhim WJ Lee JW Joh CK Park 2007 Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features AJR Am J Roentgenol 189 352 358 10.2214/AJR.07.2088 17646461 (Pubitemid 47195920)
23. JC Sheu JL Sung DS Chen PM Yang MY Lai CS Lee, et al. 1985 Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications Gastroenterology 89 259 266 1:STN:280:DyaL2M3jtFyktQ%3D%3D 2408960
24. M Ebara M Ohto T Shinagawa N Sugiura K Kimura S Matsutani, et al. 1986 Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients Gastroenterology 90 289 298 1:STN:280:DyaL28%2FotlSisw%3D%3D 2416627
25. N Okazaki M Yoshino T Yoshida M Suzuki N Moriyama K Takayasu, et al. 1989 Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report Cancer 63 2207 2210 10.1002/1097-0142(19890601)63:11<2207::AID-CNCR2820631124>3.0.CO;2-C 1:STN:280:DyaL1M3kvVyjtQ%3D%3D 2541886 (Pubitemid 19136856)
26. A Cucchetti M Vivarelli F Piscaglia B Nardo R Montalti GL Grazi, et al. 2005 Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis J Hepatol 43 310 316 10.1016/j.jhep.2005.03.014 15970351 (Pubitemid 40956885)
27. M Sherman 2001 Alphafetoprotein: an obituary J Hepatol 34 603 605 10.1016/S0168-8278(01)00025-3 1:STN:280:DC%2BD3Mzis1GitA%3D%3D 11394662 (Pubitemid 32328519)
28. F Trevisani PE D'Intino AM Morselli-Labate G Mazzella E Accogli P Caraceni, et al. 2001 Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J Hepatol 34 570 575 10.1016/S0168-8278(00)00053-2 1:STN:280:DC%2BD3Mzis1Gisw%3D%3D 11394657 (Pubitemid 32328514)
29. T Kuwahara T Sakai Y Majima K Hirai K Tanikawa 1993 Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis Hepatogastroenterology 40 347 351 1:STN:280:DyaK2c%2FhtVKktw%3D%3D 7691701
30. O Arrieta B Cacho D Morales-Espinosa A Ruelas-Villavicencio D Flores-Estrada N Hernandez-Pedro 2007 The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis BMC Cancer 7 28 10.1186/1471-2407-7-28 17288606 (Pubitemid 46351110)
31. F Farinati D Marino M De Giorgio A Baldan M Cantarini C Cursaro, et al. 2006 Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 101 524 532 10.1111/j.1572-0241. 2006.00443.x 1:CAS:528:DC%2BD28XjtlGhsLg%3D 16542289 (Pubitemid 43340928)